dc.contributor.author | SERİLMEZ, Murat | |
dc.contributor.author | Üçüncü, Muhammet Zubeyr | |
dc.contributor.author | Sari, Murat | |
dc.contributor.author | BADEMLER, Süleyman | |
dc.contributor.author | Karabulut, Senem | |
dc.date.accessioned | 2021-03-02T22:04:36Z | |
dc.date.available | 2021-03-02T22:04:36Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | BADEMLER S., Sari M., Üçüncü M. Z. , SERİLMEZ M., Karabulut S., "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer", Acta Medica Mediterranea, cilt.34, sa.6, ss.2055-2060, 2018 | |
dc.identifier.issn | 0393-6384 | |
dc.identifier.other | av_0a8bec2c-e73a-4a69-b856-afd4f233e11f | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/12822 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055662658&origin=inward | |
dc.identifier.uri | https://doi.org/10.19193/0393-6384_2018_6_320 | |
dc.language.iso | eng | |
dc.title | Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer | |
dc.type | Makale | |
dc.relation.journal | Acta Medica Mediterranea | |
dc.contributor.department | İstanbul Gelişim Üniversitesi , , | |
dc.identifier.volume | 34 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 2055 | |
dc.identifier.endpage | 2060 | |
dc.contributor.firstauthorID | 110739 | |